NCT01462006View on ClinicalTrials.gov

Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Idiopathic Pulmonary FibrosisDiffuse Parenchymal Lung DiseaseInterstitial Lung Disease
Interventions
DRUG

sirolimus

randomized to drug or placebo, followed by washout, followed by crossover

OTHER

Placebo

randomized to drug or placebo, followed by washout, followed by crossover

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Virginia

OTHER

NCT01462006 - Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF) | Biotech Hunter | Biotech Hunter